Jean-philippe P. Jacquin
Saint-priest-la-vetre, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Unveiling marine plastic degraders through DNA-stable isotope probing.
Journal: Journal of hazardous materials
Published: November 28, 2024
Eribulin efficacy in long responder patients with metastatic breast cancer: A multicentric observational study.
Journal: Cancer epidemiology
Published: November 20, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestane.
Journal: British journal of cancer
Published: June 07, 2023
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 23, 2022
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
Journal: Breast cancer (Tokyo, Japan)
Published: January 31, 2022
Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study).
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: August 25, 2020
COVID-19 and people followed for breast cancer: French guidelines for clinical practice of Nice-St Paul de Vence, in collaboration with the Collège Nationale des Gynécologues et Obstétriciens Français (CNGOF), the Société d'Imagerie de la Femme (SIFEM), the Société Française de Chirurgie Oncologique (SFCO), the Société Française de Sénologie et Pathologie Mammaire (SFSPM) and the French Breast Cancer Intergroup-UNICANCER (UCBG)
Journal: Bulletin du cancer
Published: April 13, 2020
Safety profile of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: The French HERmione non-interventional prospective study.
Journal: Breast (Edinburgh, Scotland)
Published: August 26, 2019
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14).
Journal: Breast (Edinburgh, Scotland)
Published: July 27, 2019
Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 02, 2019
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Journal: Lancet (London, England)
Published: January 20, 2019
Last Updated: 09/26/2026